KI
VRTX icon

Kapitalo Investimentos’s Vertex Pharmaceuticals VRTX Stock Holding History

Kapitalo Investimentos’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-737
Closed -$308K – 312
2024
Q1 		$308K Buy
737
+149
+25% +$63K 0.07% 164
2023
Q4 		$239K Buy
+588
New +$217K 0.05% 244
2023
Q3 		– Sell
-623
Closed -$219K – 694
2023
Q2 		$219K Buy
+623
New +$210K 0.04% 219

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Kapitalo Investimentos's VRTX Position: Q2 2024 in Review

Kapitalo Investimentos sold out of Vertex Pharmaceuticals (VRTX) in Q2 2024, closing a stake of 737 shares — an estimated $308K sold.

Kapitalo Investimentos first reported a position in VRTX in Q2 2023 and held it in 3 quarters. The position peaked at $308K in Q1 2024. 1,550 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

  • Kapitalo Investimentos reported no remaining Vertex Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Kapitalo Investimentos sold 737 Vertex Pharmaceuticals shares in Q2 2024, an estimated $308K.
  • Kapitalo Investimentos first reported a position in Vertex Pharmaceuticals in Q2 2023 and held it in 3 quarters.
  • Kapitalo Investimentos's Vertex Pharmaceuticals position peaked at $308K in Q1 2024.
  • 1,550 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on Kapitalo Investimentos's 13F filing for Q2 2024, filed 14 Aug 2024.